Leidos Holdings enters June with a fresh downgrade landing on an already-bruised stock, and the short-side data confirming that bear conviction has quietly returned over the past week.
The catalyst that changes the narrative from last week's note is today's Jefferies action. Analyst Sheila Kahyaoglu cut her rating from Buy to Hold and slashed her target from $185 to $140 — a 24% reduction that puts her new target just 10% above the current price of $126.82. That is one of the more aggressive target resets from a bellwether firm in recent months, and it lands when the stock is already down 15% over the past month. The broader analyst community has been moving in the same direction. Since the Q1 print on May 5 — when the stock fell 9.3% on the day and 13.7% over the following week — Citigroup, Stifel, and RBC Capital all trimmed targets while holding their existing ratings. BofA and Truist had already lowered targets in April. The consensus now clusters around Hold, with 9 of 14 analysts at that stance. The mean target of $183 looks increasingly distant from where the stock actually trades, suggesting the target stack will continue to drift lower as reviews are refreshed.
Short interest has moved in a direction that corroborates the more cautious Street tone. The absolute share count jumped roughly 35% over the past week — from about 3.3 million to 4.5 million shares — lifting SI as a percentage of free float to 3.5%, the highest level seen in the 30-day data window. That is a meaningful shift. The previous note from May 27 described SI at 2.6% of float and falling; it has now reversed sharply. Importantly, the borrow market remains entirely untroubled by this increase. Availability is extraordinarily loose at roughly 5,596% of short interest — meaning there are nearly 56 shares available to borrow for every one already lent out. Cost to borrow is also negligible at 0.35% APR, down sharply from the brief spike to 1.77% seen on May 26. Building a short position in Leidos costs almost nothing and faces no mechanical friction whatsoever.
Options positioning has meanwhile returned to near-neutral after the defensive spike that dominated mid-May. The put/call ratio is 0.85, virtually flat against its 20-day mean of 0.85 and carrying a z-score of essentially zero. The 52-week high on the PCR was 1.40; the current reading is well below that. What this means in practice is that options traders are not adding meaningful new downside hedges on top of the Jefferies downgrade — the fear expressed in late May via elevated put demand has not re-ignited. That creates an interesting divergence: short sellers are rebuilding positions methodically, while options participants remain comparatively calm.
The bull and bear cases for Leidos are well-defined. Bulls point to a genuinely diversified government IT franchise spanning DoD, intelligence, DHS, FAA, and VA, with exposure to high-priority spend areas like digital modernisation and space. The EV/EBITDA multiple has compressed to roughly 8x, and the earnings yield now runs just above 10% — undemanding relative to the company's contract backlog quality. The factor scores support this view selectively: the dividend score sits in the 97th percentile, and EV/EBIT ranks in the 85th. Bears counter with a more immediate concern — the Q1 book-to-bill of 0.8x signals that new orders are running below revenue, government spending risk remains elevated, and the May earnings print produced the worst single-session reaction in recent memory. The ORTEX short score of 36.9 is moderate and has edged marginally higher over the past week, consistent with rising SI rather than a full repositioning.
Among peers, this week's divergence is notable. SAIC and KBR gained 11.8% and 6.6% respectively over the week, while Booz Allen Hamilton added just 0.5%. Leidos slipped 1%, making it a relative underperformer against the group despite its previously stronger year-to-date positioning. The next scheduled earnings event is August 4 — and given that the prior print drove a 9.3% one-day decline and a 13.7% five-day decline, the trajectory of order intake and book-to-bill between now and then is the data point most worth tracking.
See the live data behind this article on ORTEX.
Open LDOS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
